OPGN OpGen Inc

OpGen, Inc. (NASDAQ: OPGN) today announced that the Company will report financial results for the three and nine months ended September 30, 2018 after the close of the U.S. financial markets on Tuesday, November 13, 2018. OpGen’s management team will host a live conference call and audio webcast at 4:30 p.m. Eastern time to discuss the Company’s financial results and business progress.

Dial-in InformationU.S. Dial-In Number: (888) 883-4599            International Dial-In Number: (484) 653-6821          Conference ID: 9163687

Replay Dial-in InformationU.S. Dial-In Number: (855) 859-2056   International Dial-In Number: (404) 537-3406Conference ID: 9163687

Following the conclusion of the conference call, a replay will be available through November 19, 2018. The live, listen-only webcast of the conference call may also be accessed by visiting the investors section of the Company’s website at www.ir.opgen.com. A replay of the webcast will be available after the conclusion of the call and will be archived on the Company’s website for 90 days.

About OpGen

OpGen, Inc. is harnessing the power of informatics and genomic analysis to provide complete solutions for patient, hospital, and network-wide infection prevention and treatment. For more information, please visit www.opgen.com.

OpGen Contact: Michael Farmer Vice President, Marketing (240) 813-1284mfarmer@opgen.comInvestorRelations@opgen.com

Investor Contacts: LHA Investor Relations Kim Sutton Golodetz (212) 838-3777 kgolodetz@lhai.com or Bruce Voss (310) 691-7100 bvoss@lhai.com

Media ContactMatt BretziusFischTank Marketing and PRmatt@fischtankpr.com